Immunomodulation and metabolismpossible role of lactoferrin

  1. Moreno Navarrete, J. M.
Dirigée par:
  1. José Manuel Fernández Real Lemos Directeur/trice

Université de défendre: Universitat de Girona

Fecha de defensa: 20 juin 2011

Jury:
  1. Antonio Zorzano Olarte President
  2. Victoria Catalán Goñi Secrétaire
  3. Carmen Carretero Romay Rapporteur
  4. Joan Vendrell Ortega Rapporteur
  5. Maria Vilanova Brugués Rapporteur

Type: Thèses

Teseo: 312348 DIALNET lock_openTDX editor

Résumé

To gain insight in the relationship between innate immune system and metabolic disease, we aimed to investigate the effects of lactoferrin in obesity-related metabolic disturbances. Circulating lactoferrin concentration was significantly decreased in subjects with altered glucose tolerance (AGT) and associated negatively with obesity-related metabolic disturbances. The SNPs-induced aminoacidic changes in lactoferrin N-terminus region were associated with a low atherogenic lipid profile. Lactoferrin production in neutrophils decreased significatively in aging, chronic low-grade inflammation and type 2 diabetes. In vitro, lactoferrin increased insulin signaling pathway, even under insulin resistance conditions and displayed dual effects on adipogenesis (antiadipogenic in 3T3-L1 and adipogenic in human adipocytes). In conclusion, lactoferrin might play a potential protective role against insulin resistance and obesity related metabolic disturbances.